The LTV Parthenon: A First-Principles Way To Build Profitable Subscription Businesses

When you strip the problem down to first principles, value creation in e-commerce subscription businesses comes down to only ...

Milestone Pharmaceuticals: Selling The News On Cardamyst Approval Makes No Sense

Cardamyst FDA approval and launch for PSVT, solid cash, and big expansion upside. Click for more on MIST stock.